2-Bromo-N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)benzenesulfonamide
97%
- Product Code: 124092
CAS:
415697-57-3
| Molecular Weight: | 375.24 g./mol | Molecular Formula: | C₁₃H₁₅BrN₂O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. It is particularly valuable in the development of sulfonamide-based pharmaceuticals, which are known for their diverse therapeutic applications, including antimicrobial, anti-inflammatory, and anticancer properties. Its structural features, such as the bromo and isoxazole moieties, make it a versatile building block for designing compounds with enhanced binding affinity and specificity toward target proteins. Additionally, it is employed in research settings to explore structure-activity relationships (SAR) in drug discovery, aiding in the optimization of drug candidates for improved efficacy and reduced side effects.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | Ft96,966.97 |
+
-
|
2-Bromo-N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)benzenesulfonamide
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. It is particularly valuable in the development of sulfonamide-based pharmaceuticals, which are known for their diverse therapeutic applications, including antimicrobial, anti-inflammatory, and anticancer properties. Its structural features, such as the bromo and isoxazole moieties, make it a versatile building block for designing compounds with enhanced binding affinity and specificity toward target proteins. Additionally, it is employed in research settings to explore structure-activity relationships (SAR) in drug discovery, aiding in the optimization of drug candidates for improved efficacy and reduced side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :